(Q34164024)

31 July 2017

title

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon (English)

1 reference

31 July 2017

0 references

Jean Pierre Raynaud

1

1 reference

31 July 2017

Henri Cousse

series ordinal

2

1 reference

31 July 2017

Pierre Marie Martin

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 October 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

31 July 2017

published in

1 reference

31 July 2017

volume

82

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

233-239

1 reference

The pathogenesis of benign prostatic hyperplasia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Presence of 5alpha-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Inhibition of steroid 5α-reductase by specific aliphatic unsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Phytotherapy in the treatment of benign prostatic hyperplasia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Testosterone 5α-reductase inhibition by free fatty acids from Sabal serrulata fruits

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Baculovirus-directed expression of human prostatic steroid 5 alpha-reductase 1 in an active form

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Partial purification of human prostatic 5 alpha-reductase (3-oxo-5 alpha-steroid:NADP+ 4-ene-oxido-reductase; EC 1.3.1.22) in a stable and active form.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Phospholipid requirement of epididymal testosterone 5 alpha-reductase and phospholipid composition of epididymal microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Lipid composition in epithelium and stroma of human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900187-5

7 January 2021

10.1016/S0960-0760(02)00187-5

Identifiers

DOI

1 reference

31 July 2017

1 reference